StackTerminal.Health

BETA

Berberine HCl

Berberine HCl is a hydrochloride salt form of berberine that improves solubility & is known for its AMPK-activating mechanism, showing evidence for glycemic control, lipid profiles, & metabolic syndrome management.

metabolicblood sugarcardiovasculargut health

Evidence last reviewed: 05 Apr 2026

Evidence
5 records
5 recordsBest grade:Moderate
Biomarkers
LDL CholesterolHDL CholesterolTriglyceridesBlood GlucoseInsulin SensitivityHbA1c

Moderate evidence supports berberine HCl's role in improving lipid profiles and insulin sensitivity in adults with metabolic syndrome and type 2 diabetes. However, the evidence for glycemic control in prediabetic adults is limited and requires further investigation.

Glycemic control
Prediabetic adults · RCT
Low

The study aims to evaluate the efficacy of a polyherbal dietary supplement on glycemic parameters in prediabetic adults.

Dose: 1500 mg
The study is a protocol & does not provide specific results.
Lipid profile improvement
Adults with metabolic syndrome · RCT
Moderate

Berberine HCl supplementation improved lipid profiles in adults with metabolic syndrome.

Dose: 1500 mgDuration: 12 weeksForm: HydrochlorideTiming: With meals
Based on known pharmacology & typical dosing.
Improved insulin sensitivity
Adults with type 2 diabetes · RCT
Moderate

Berberine HCl improved insulin sensitivity in adults with type 2 diabetes.

Dose: 1500 mgDuration: 3 monthsForm: HydrochlorideTiming: Twice daily
Based on known pharmacology & typical dosing.
Dyslipidemia — LDL, triglycerides, total cholesterol
Adults with dyslipidemia · Systematic review and meta-analysis of RCTs
Moderate

Berberine reduced LDL cholesterol by 0.46 mmol/L, triglycerides by 0.34 mmol/L, & total cholesterol by 0.48 mmol/L across 18 RCTs; HDL changes differed by sex (increase in women, slight decrease in men). No serious adverse events reported.

Dose: 900–1500 mgDuration: 4–24 weeks
Glycemic control in type 2 diabetes
Adults with type 2 diabetes · Systematic review and meta-analysis of RCTs
Moderate

Berberine reduced fasting plasma glucose by 0.82 mmol/L, HbA1c by 0.63%, & 2-hour postprandial glucose by 1.16 mmol/L across 37 RCTs (n=3048); glucose-lowering effect correlated with baseline glucose levels.

Dose: 500–1500 mgDuration: 8–24 weeks
Stacks containing Berberine HCl
Explore all →
metabolicblood-sugarweight-management

This stack combines berberine-hcl & chromium-picolinate to enhance metabolic health & regulate blood sugar levels. Berberine has been shown to improve insulin sensitivity, while chromium-picolinate supports glucose metabolism.

Berberine HCl
500mg
Chromium Picolinate
200mg
New
View
metaboliclongevityhealthspan

Targets glucose & lipid markers for long-term metabolic health.

Berberine HCl
10000mg
Coenzyme Q10
200mg
New
View
dailylongevity

Foundational stack aimed at mitochondrial function, insulin sensitivity, & long-term healthspan.

Omega-3 (EPA/DHA)
2000mg
Vitamin D3
50mg
Berberine HCl
1000mg
New
View
longevity

Targets glucose & lipid markers for long-term metabolic health.

Berberine HCl
1000mg
Coenzyme Q10
200mg
New
View
Community Insights
Forms & usage
How to take it

Take 500 mg two to three times daily with meals.

Hydrochloride
Improved solubility compared to other forms.
Capsule
Commonly used for ease of dosing.
Tablet
Standardized dosing form.
My notes
Sign in to keep a private note on Berberine HCl.